Data on margin financing for several new share offerings is available.

As of June 1, Dajin Heavy Industry (01081), Longbio-B (01779), and Lung Fung Group (02290) are in the process of their public offerings.

According to information from securities firms including Futu Securities and Phillip Securities, Dajin Heavy Industry has seen margin financing of HK$17.459 billion, representing an oversubscription of over 29.23 times.

Longbio-B has attracted margin financing of HK$164.953 billion, indicating an oversubscription exceeding 1,208.84 times.

Lung Fung Group has recorded margin financing of HK$6.306 billion, which translates to an oversubscription of over 78.07 times.